Lipigon Pharmaceuticals
0,118
SEK
-8,84 %
Mindre end 1K følgere
LPGO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-8,84%
+6,72%
+1,91%
+1,91%
-53,61%
-67,42%
-96,5%
-
-98,41%
Lipigon Pharmaceuticals operates in the pharmaceutical industry. The company specializes in the research and development of various drug candidates. The product portfolio is broad and includes drugs for rare diseases. These are mainly treatments for diseases caused by disorders in the body's handling of fats. In addition to the main business, service and associated ancillary services are also offered. Lipigon Pharmaceuticals operates worldwide, with the largest presence in the Nordic market.
Læs mereMarkedsværdi
17,44 mio. SEK
Aktieomsætning
302,34 t SEK
Omsætning
10,29 mio.
EBIT %
-248,62 %
P/E
-
Udbytteafkast, %
-
Finanskalender
28.4
2025
Ekstraordinær generalforsamling '25
22.5
2025
Generalforsamling '25
27.5
2025
Delårsrapport Q1'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Lipigon Pharmaceuticals' commercial partner announces positive results from Phase I clinical trial with Lipisense
Redeye: Lipigon Q3 2024 - First Patient Recruited
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools